电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

PROCR 抗体 (FITC)

This anti-PROCR antibody is a 大鼠 单克隆 antibody detecting PROCR in WB, IP 和 Func. Suitable for 人.
产品编号 ABIN1106044
发货至: 中国

Quick Overview for PROCR 抗体 (FITC) (ABIN1106044)

抗原

See all PROCR 抗体
PROCR (Protein C Receptor, Endothelial (PROCR))

适用

  • 55
  • 15
  • 15
  • 2
  • 1
  • 1

宿主

  • 58
  • 13
  • 7
大鼠

克隆类型

  • 59
  • 19
单克隆

标记

  • 51
  • 14
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This PROCR antibody is conjugated to FITC

应用范围

  • 59
  • 41
  • 23
  • 19
  • 16
  • 12
  • 11
  • 6
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Immunoprecipitation (IP), Functional Studies (Func)

克隆位点

RCR-252
  • 交叉反应 (详细)

    Species reactivity (tested):Human

    纯化方法

    Protein G

    亚型

    IgG1
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 浓度

    0.1 mg/mL

    缓冲液

    PBS, 1 % bovine serum

    储存条件

    4 °C

    储存方法

    Store at 2 - 8 °C.
  • 抗原

    PROCR (Protein C Receptor, Endothelial (PROCR))

    别名

    CD201 / EPCR

    背景

    Endothelial protein C receptor (EPCR) is a highly glycosylated type I transmembrane protein of 221-amino-acids. These amino acids comprise an extracellular domain, a 25-aa transmembrane domain, and a short (3 aa) intracytoplasmic sequence coding for an ~46 kDa protein. Deglycosylation will reduce the protein mass to 25 kDa. EPCR is expressed strongly on the endothelial cells of arteries and veins in heart and lung, less intensely in capillaries in the lung and skin, and not at all in the endothelium of small vessels of the liver and kidney. EPCR is the receptor for protein C, a key player in the anticoagulation pathway. The protein C anticoagulant pathway serves as a major system for controling thrombosis, limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. The essential components of the pathway include thrombin, thrombomodulin, the endothelial cell protein C receptor (EPCR), protein C and protein S. The pathway is initiated when thrombin binds to thrombomodulin on the surface of endothelium. EPCR augments protein C activation by binding protein C and presenting it to the thrombin-thrombomodulin activation complex. Activated protein C (aPC) retains its ability to bind EPCR, and this complex appears to be involved in some of the cellular signaling mechanisms that down-regulate inflammatory cytokine formation (TNF, IL-6). EPCR is shed from the vasculature by inflammatory mediators and thrombin. EPCR binds to activated neutrophils in a process that involves proteinase 3 and Mac-1. Furthermore, EPCR can undergo translocation from the plasma membrane to the nucleus. EPCR can be cleaved to release a soluble form (sEPCR) in the circulation. This sEPCR is detected as a single species of 43 kDa, resulting from shedding of membrane EPCR by the action of a metalloprotease, which is stimulated by thrombin and by some inflammatory mediators. Soluble EPCR binds PC and aPC with similar affinity, but its binding to aPC inhibits the anticoagulant activity of aPC by blocking its binding to phospholipids and by abrogating its ability to inactivate factor Va. sEPCR can be detected in plasma. In normal persons, sEPCR is present in levels of 83.6 +/- 17.2 ng/mL. Elevated levels of sEPCR are positively correlated to a higher risk for thrombosis. Furthermore, a haplotype (A3 allele) has been linked to elevated levels of sEPCR (264 +/-174 ng/mL).Synonyms: APC receptor, Activated protein C receptor, Endothelial cell protein C receptor, Endothelial protein C receptor, PROCR

    UniProt

    Q9UNN8
You are here:
Chat with us!